期刊
PLOS ONE
卷 17, 期 1, 页码 -出版社
PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0262482
关键词
-
资金
- Plastic Omnium Auto Sp. z o.o.
Based on in silico screening, factor Xa inhibitors were suggested to potentially inhibit SARS-CoV-2 M-pro. However, our study found that the binding affinity of Apixaban, Betrixaban, and Rivaroxaban to SARS-CoV-2 M-pro was weak, indicating a negligible therapeutic effect.
Based on previous large-scale in silico screening several factor Xa inhibitors were proposed to potentially inhibit SARS-CoV-2 M-pro. In addition to their known anticoagulants activity this potential inhibition could have an additional therapeutic effect on patients with COVID-19 disease. In this study we examined the binding of the Apixaban, Betrixaban and Rivaroxaban to the SARS-CoV-2 M-pro with the use of the MicroScale Thermophoresis technique. Our results indicate that the experimentally measured binding affinity is weak and the therapeutic effect due to the SARS-CoV-2 M-pro inhibition is rather negligible.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据